A randomized controlled trial of single-dose oral ivermectin in patients with Covid-19 infection | India Science, Technology & Innovation - ISTI Portal

×

Accessibility Controls

A randomized controlled trial of single-dose oral ivermectin in patients with Covid-19 infection

Implementing Organization

All India Institute of Medical Sciences, Delhi

Principal Investigator

Dr. A. Mohan Professor & Head All India Institute of Medical Sciences Ansari Nagar Delhi

Related Research

Funding Organization

Funding Organization

Department of Science and Technology (DST)

Quick Information

Area of Research

Medical Sciences

Focus Area

Science & Engineering Research Board - Covid-19 (SERB-COVID)

Start Date

2020

End Date

2021

Duration

12

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

Publications

00

No. of Patents

Filed : 00

Grant : 00

Latest Updates

Loading…